A case of acanthosis nigricans in a HIV-infected patient

BMC Infect Dis. 2020 May 20;20(1):360. doi: 10.1186/s12879-020-05089-1.

Abstract

Background: To date, very little information is available concerning the relationship between acanthosis nigricans (AN) and infection with human immunodeficiency virus type 1 (HIV-1).

Case presentation: Herein, we report the case of a middle-aged man admitted for fever and progressively worsening dyspnea in the context of an opportunistic pneumonia and firstly diagnosed with acquired immunodeficiency syndrome (AIDS). At the time of diagnosis, physical examination revealed the presence of a palpable, hyperpigmented skin lesion on the left areola with surface desquamation and velvety texture consistent with AN. Of note, the most common primary etiologies related to AN were excluded and the complete regression of the skin lesion was observed once antiretroviral therapy was started.

Conclusion: This is the second report of AN found in patients with AIDS and apparently responsive to prolonged antiretroviral treatment. Possible explanations of this association are still not completely understood, probably related to virus-induced changes in lipid metabolism. Our experience suggests that HIV testing should always be considered in the setting of apparently idiopathic AN.

Keywords: Acanthosis nigricans; Antiretroviral therapy; Case report; HIV-1 infection; Metabolic syndrome.

Publication types

  • Case Reports

MeSH terms

  • Acanthosis Nigricans / drug therapy
  • Acanthosis Nigricans / etiology*
  • Acquired Immunodeficiency Syndrome / complications*
  • Acquired Immunodeficiency Syndrome / drug therapy
  • Anti-HIV Agents / therapeutic use
  • HIV-1 / physiology
  • Humans
  • Male
  • Middle Aged
  • Virus Activation

Substances

  • Anti-HIV Agents